The effect of sorafenib on diastolic blood pressure in patients with advanced solid tumours

Trial Profile

The effect of sorafenib on diastolic blood pressure in patients with advanced solid tumours

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Mar 2014

At a glance

  • Drugs Sorafenib (Primary)
  • Indications Solid tumours
  • Focus Pharmacodynamics
  • Most Recent Events

    • 17 Mar 2014 Results published in the Clinical Pharmacology and Therapeutics.
    • 17 Jun 2011 New trial record
    • 07 Jun 2011 Results presented at the 47th Annual Meeting of the American Society of Clinical Oncology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top